According to HSAs June 2025 approval notice, Tirzepatide KwikPen was approved in Singapore for weight management, including weight loss and weight maintenance, in adults with an initial BMI of at least 30, or BMI 27 to under 30 with at least one weight-related comorbid condition such as hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes
An evidence-based blend of Calcium-D-Glucarate, DIM, I-3-C and Sulforaphane to support proper estrogen metabolism through liver and digestive detoxification
1 In an attempt to help in the discovery of pharmaceuticals for the treatment of diseases, Creative Biolabs succeeded in developing a speedy and steady Hi-Affi in vitro cell-based somatostatin receptor functional assay service , which is currently offered to customers throughout the world
Its also a controlled substance with abuse potential